Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly

NCT01951118 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT01951118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01951118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2013
Completion date
May 31, 2019
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, delirium, dementia, amnestic, cognitive disorders, mild cognitive impairment